title: Diacylglycerol kinase θ: regulation and stability.
abstract: Given the well-established roles of diacylglycerol (DAG) and phosphatidic acid (PtdOH) in a variety of signaling cascades, it is not surprising that there is an increasing interest in understanding their physiological roles and mechanisms that regulate their cellular levels. One class of enzymes capable of coordinately regulating the levels of these two lipids is the diacylglycerol kinases (DGKs). These enzymes catalyze the transfer of the γ-phosphate of ATP to the hydroxyl group of DAG, which generates PtdOH while reducing DAG. As these enzymes reciprocally modulate the relative levels of these two signaling lipids, it is essential to understand the regulation and roles of these enzymes in various tissues. One system where these enzymes play important roles is the nervous system. Of the ten mammalian DGKs, eight of them are readily detected in the mammalian central nervous system (CNS): DGK-α, DGK-β, DGK-γ, DGK-η, DGK-ζ, DGK-ι, DGK-ε, and DGK-θ. Despite the increasing interest in DGKs, little is known about their regulation. We have focused some attention on understanding the enzymology and regulation of one of these DGK isoforms, DGK-θ. We recently showed that DGK-θ is regulated by an accessory protein containing polybasic regions. We now report that this accessory protein is required for the previously reported broadening of the pH profile observed in cell lysates in response to phosphatidylserine (PtdSer). Our data further reveal DGK-θ is regulated by magnesium and zinc, and sensitive to the known DGK inhibitor R599022. These data outline new parameters involved in regulating DGK-θ.
authors.affiliation: Department of Biological Chemistry, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205-2185, USA.
authors.forename: Becky
authors.initials: B
authors.lastname: Tu-Sekine
authors.forename: Hana
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Petro
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Raben
mesh_terms: D000818:Animals; D002413:Cations, Divalent; D045744:Cell Line, Tumor; D002490:Central Nervous System / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D019852:Diacylglycerol Kinase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D004075:Diglycerides / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004795:Enzyme Stability / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D008274:Magnesium / Q000378:metabolism; D051379:Mice; D041681:NIH 3T3 Cells; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D010712:Phosphatidic Acids / Q000378:metabolism*; D010718:Phosphatidylserines / Q000494:pharmacology; D011744:Pyrimidinones / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D013844:Thiazoles / Q000494:pharmacology; D015032:Zinc / Q000378:metabolism
chemical_list: C011439:1,2-diacylglycerol; D002413:Cations, Divalent; D004075:Diglycerides; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D010712:Phosphatidic Acids; D010718:Phosphatidylserines; D011744:Pyrimidinones; D013844:Thiazoles; C047505:R 59022; D019852:Diacylglycerol Kinase; D008274:Magnesium; D015032:Zinc